Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (201-210 of 509) with videos related to

Pageof 51
Sort By:
Diabetes, Obesity & Metabolism|August 10, 2011
Regulation of glucagon secretion by incretinsJ J Holst, M Christensen, A Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2016
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 DiabetesDavid P Sonne, F Samuel van Nierop, Willem Kulik, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 DiabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Journal of the Endocrine Society|September 9, 2020
Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 DiabetesMikkel B Christensen, Asger B Lund, Niklas R Jørgensen, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
Adult atopic dermatitis and the risk of type 2 diabetesYuki M F Andersen, Alexander Egeberg, Gunnar H Gislason, et al.
Der Nervenarzt|April 5, 2008
[Neurolymphomatosis. Subacute sensorimotor polyneuropathy as a first sign of non-Hodgkin's B cell lymphoma]P P Urban, E Kaczmarek, I Wellach, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 25, 2014
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetesS Calanna, R Scicali, A Di Pino, et al.
BMC Medicine|August 16, 2012
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefitsBjørn H Ebdrup, Filip K Knop, Pelle L Ishøy, et al.
European Journal of Endocrinology|March 30, 2022
THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacologyDavid S Mathiesen, Asger Lund, Jens J Holst, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 3, 2015
The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
Pageof 51

Showing results (201-210 of 509) with videos related to

Sort By:
Pageof 51
Diabetes, Obesity & Metabolism|August 10, 2011
Regulation of glucagon secretion by incretinsJ J Holst, M Christensen, A Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2016
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 DiabetesDavid P Sonne, F Samuel van Nierop, Willem Kulik, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 DiabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Journal of the Endocrine Society|September 9, 2020
Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 DiabetesMikkel B Christensen, Asger B Lund, Niklas R Jørgensen, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
Adult atopic dermatitis and the risk of type 2 diabetesYuki M F Andersen, Alexander Egeberg, Gunnar H Gislason, et al.
Der Nervenarzt|April 5, 2008
[Neurolymphomatosis. Subacute sensorimotor polyneuropathy as a first sign of non-Hodgkin's B cell lymphoma]P P Urban, E Kaczmarek, I Wellach, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 25, 2014
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetesS Calanna, R Scicali, A Di Pino, et al.
BMC Medicine|August 16, 2012
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefitsBjørn H Ebdrup, Filip K Knop, Pelle L Ishøy, et al.
European Journal of Endocrinology|March 30, 2022
THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacologyDavid S Mathiesen, Asger Lund, Jens J Holst, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 3, 2015
The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
Pageof 51